STOCKWATCH
·
Pharmaceuticals
Quarterly Result25 Feb 2026, 08:23 pm

Sanofi Consumer Healthcare India Ltd Approves Re-Appointment of Cost Auditor and Recommends Dividend

AI Summary

The Board of Directors of Sanofi Consumer Healthcare India Ltd approved the re-appointment of M/s. Kishore Bhatia & Associates as the Cost Auditor for the Financial Year ending 31st December 2026. The Board also recommended a final dividend of Rs. 75/- per equity share for the Financial Year ended 31st December 2025, subject to approval by shareholders at the ensuing Annual General Meeting (AGM).

Key Highlights

  • Re-appointment of Cost Auditor for the Financial Year ending 31st December 2026
  • Recommendation of final dividend of Rs. 75/- per equity share for the Financial Year ended 31st December 2025
SANOFICONR
Pharmaceuticals
Sanofi Consumer Healthcare India Ltd

Price Impact